Protocols

Protocols

Below are the generic I-MOVE protocols for various outcomes and study designs. If you are part of the I-MOVE multicentre study teams, please go to the hospital network or primary care network pages for study site-specific protocols (for which access is restricted).

I-MOVE primary care multicentre study generic protocol

​This is the I-MOVE primary care test-negative design multicentre study generic protocol. Study sites can use this protocol together with study site-specific annexes. This protocol also covers the pooled analysis.

I-MOVE hospital multicentre study generic protocol

​This is the I-MOVE hospital test-negative design multicentre study generic protocol. Study sites can use this protocol together with study site-specific annexes. This protocol also covers the pooled analysis.

I-MOVE laboratory generic protocol

In this I-MOVE laboratory generic protocol, we outline procedures to attempt to obtain a representative sample of viruses to sequence (which includes random selection).

I-MOVE+ generic protocol for screening method

This is the generic protocol for measuring influenza vaccine effectiveness among the elderly population using the screening method in the European Union and European Economic Area Member States. This protocol was created as part of the                                 I-MOVE+ project (2015–18).

I-MOVE+ generic protocol for impact

This is the generic protocol for measuring the impact of influenza vaccination programmes among the elderly population in the European Union and European Economic Area Member States. This protocol was created as part of the I-MOVE+ project                           (2015–18).